DENTSPLY SIRONA Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2021 / 01:40PM GMT
Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everyone. Thanks for joining this session with Dentsply Sirona. My name is Nathan Rich, and I cover the Dental Space here at Goldman Sachs. Today, we're joined by Jorge Gomez, Dentsply Sirona's CFO; and Andrea Daley from Investor Relations.

Before we jump into the Q&A, I just wanted to remind the audience that if anyone would like to ask a question during the course of this presentation, you can either send me an e-mail directly to [email protected], or you can use the ask a question function through the webinar.

So Jorge, thanks so much for joining us and for your time today. I think we'll just jump right into questions.

Questions and Answers:

Nathan Allen Rich - Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe starting at a high level with the long-term revenue guidance, the company has kind of guided to long-term revenue growth of 4% to 5%. That was following the acquisition of BYTE. That's faster than the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot